The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
J.E. Berchuck(Brigham and Women's Hospital), Love Goyal(The Christie NHS Foundation Trust), Mitesh J. Borad(Jacksonville College), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Daniel DiToro(Brigham and Women's Hospital), Luc Friboulet(Inserm), R. Sharman(University of Arizona), Jochen Maurer(Universitätsklinikum Aachen), Umair Majeed(Mayo Clinic in Florida), Aparna R. Parikh(Massachusetts General Hospital), Islam Baiev(Massachusetts General Hospital), Benjamin Kye Jyn Tan(National University of Singapore), Meng‐Ju Wu(Broad Institute), Pedro Luiz Serrano Usón(Hospital Israelita Albert Einstein), Lesli A. Kiedrowski(Guardant (United States)), Kabir Mody(Mayo Clinic in Florida), Colin C. Pritchard(Animal and Plant Health Agency), M. M. Javle(The University of Texas MD Anderson Cancer Center), Jochen K. Lennerz(Addgene), Sylvia A. Reyes(Duke University), Daniel V.T. Catenacci(University of Chicago), Antoine Hollebecque(Institut Gustave Roussy), Dejan Juric(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Karen Zhang(UCSF Helen Diller Family Comprehensive Cancer Center), Christopher S. Chen(Inspire), Francesco Facchinetti(Inserm), Nabeel Bardeesy(Broad Institute), Rachna T. Shroff(University of Arizona)
Cited by 138
Related Papers
Geometric Control of Cell Life and Death
|Science|1997|4.7k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k